Evidence map›Paper›PMID 37145711›Full record

ArticleCardiovascular journal of Africa

Improving cardiovascular outcomes for patients with heart failure in sub-Saharan Africa: conference proceedings of the 2022 Nigerian Cardiovascular Symposium.

Onyedika J Ilonze, Albert Hicks, Bayo Atanda, Mahmoud H Abdou, Chioma Onyekwelu, Ebere Chukwu, Kamilu M Karaye, Ibraheem Katibi, Okechukwu S Ogah, Obi Emerole and 4 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiovascular journal of Africa. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Onyedika J IlonzeDivision of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, IN, USA. Email: oilonze@iu.edu.
Albert HicksDivision of Cardiovascular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Bayo AtandaWinchester Cardiology and Vascular Medicine, Winchester, VA, USA.
Mahmoud H AbdouDivision of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Chioma OnyekweluDepartment of Cardiology, Norton Healthcare, Louisville, KY, USA.
Ebere ChukwuDepartment of Cardiology, Baylor Scott and White, Temple, TX, USA.
Kamilu M KarayeDepartment of Medicine, Aminu Kano Teaching Hospital; Department of Medicine, Bayero University, Kano, Nigeria.
Ibraheem KatibiUniversity of Ilorin, PMB 1515; University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Okechukwu S OgahDivision of Cardiology, Department of Medicine, University College Hospital, Ibadan, Nigeria.
Obi EmeroleDivision of Cardiology, Department of Internal Medicine, Atrium Health Navicent, Macon, GA, USA.
Jane N AjuluchukwuDepartment of Medicine, Division of Cardiology, University of Lagos, Lagos, Nigeria.
Mahmoud U SaniDepartment of Medicine, Aminu Kano Teaching Hospital; Department of Medicine, Bayero University, Kano, Nigeria.
Christopher C AsuzuDivision of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Modele O OgunniyiDivision of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Funding

Program to Increase Diversity in Cardiovascular Health-Related Research(PRIDE-CVD)R25HL105446 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI Mohamed Boutjdir · 2010 to 2026
$5.9M
NHLBI NIH HHS R25 HL105446
6 · The paper itself

Abstract

The Nigerian Cardiovascular Symposium is an annual conference held in partnership with cardiologists in Nigeria and the diaspora to provide updates in cardiovascular medicine and cardiothoracic surgery with the aim of optimising cardiovascular care for the Nigerian population. This virtual conference (due to the COVID-19 pandemic) has created an opportunity for effective capacity building of the Nigerian cardiology workforce. The objective of the conference was for experts to provide updates on current trends, clinical trials and innovations in heart failure, selected cardiomyopathies such as hypertrophic cardiomyopathy and cardiac amyloidosis, pulmonary hypertension, cardiogenic shock, left ventricular assist devices and heart transplantation. Furthermore, the conference aimed to equip the Nigerian cardiovascular workforce with skills and knowledge to optimise the delivery of effective cardiovascular care, with the hope of curbing 'medical tourism' and the current 'brain drain' in Nigeria. Challenges to optimal cardiovascular care in Nigeria include workforce shortage, limited capacity of intensive care units, and availability of medications. This partnership represents a key first step in addressing these challenges. Future action items include enhanced collaboration between cardiologists in Nigeria and the diaspora, advancing participation and enrollment of African patients in global heart failure clinical trials, and the urgent need to develop heart failure clinical practice guidelines for Nigerian patients.

Indexed as

CardiomyopathiesCOVID-19Heart FailureHeartHumansPandemicsadvanced heart failurecardiac amyloidosiscardiogenic shockcardiomyopathyheart failureheart transplantationhypertrophic cardiomyopathyleft ventricular assist deviceNigeriapulmonary hypertensionsub‐Saharan Africa

Identifiers

PMID37145711
PMCPMC10512044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.